Holen Sie sich die Stockscreener-App
231.41
2.19%
4.97
Schlusskurs vom Vortag:
$226.44
Offen:
$232.64
24-Stunden-Volumen:
2.63M
Relative Volume:
1.87
Marktkapitalisierung:
$33.14B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-141.00
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+5.56%
1M Leistung:
+20.19%
6M Leistung:
+2.97%
1J Leistung:
+35.34%
1-Tages-Spanne:
$227.93
$237.15
1-Wochen-Bereich:
$208.79
$237.15
52-Wochen-Spanne:
$131.81
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
231.41 | 33.14B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
464.61 | 172.66B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.17 | 125.40B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.09 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
127.06 | 35.89B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.44 | 34.90B | 3.77B | 449.25M | 240.68M | 7.8556 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress - Yahoo Finance UK
Natera director Rowan Chapman sells $642,535 in stock By Investing.com - Investing.com Australia
Insider Sell: Rowan Chapman Sells 2,964 Shares of Natera Inc (NT - GuruFocus
Natera Inc (NTRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Natera co-founder Sheena Jonathan sells $665,087 in shares By Investing.com - Investing.com Nigeria
Natera director Rowan Chapman sells $642,535 in stock - Investing.com India
Natera (NTRA) co-founder Sheena Jonathan sells 3,150 shares in 10b5-1 plan trades - Stock Titan
Natera Inc (NTRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Natera Inc (NTRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Natera Inc (NTRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Is Natera’s CytoDyn ctDNA Tie-Up and Board Refresh Reframing the Investment Case for NTRA? - simplywall.st
Natera (NTRA), CytoDyn Announce Strategic Collaboration for ctDNA-Guided mCRC Clinical Trials - Yahoo Finance
Natera executive chairman sells $21.4 million in shares By Investing.com - Investing.com South Africa
Natera executive chairman sells $21.4 million in shares - Investing.com
Executive chairman of Natera (NTRA) sells 100,000 shares in Rule 10b5-1 trades - Stock Titan
Natera shareholders approve equity plan amendment and elect directors at annual meeting - Investing.com UK
Thomas Lynch joins Natera (NASDAQ: NTRA) board as new independent director - Stock Titan
Natera (NASDAQ: NTRA) OKs equity plan share boost and director slate - Stock Titan
[144] Natera, Inc. SEC Filing - Stock Titan
Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA) - Yahoo Finance
Natera Inc (NTRA) Institutional Confidence - TradingKey
Natera expands Austin operations with new sequencing facility - MSN
Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews
Billionaire Stanley Druckenmiller’s Top Bet: Natera (NTRA) and the Rise of Liquid Biopsy TestingMid-Term Outlook - newsline.com
Natera to launch enhanced Panorama NIPT for low fetal fractions - MSN
Natera Shares Slide Over 3% as Stock Tests Key Support LevelsCharm Flow - newsline.com
Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock - Insider Monkey
Morgan Stanley files Form 144 for 100,000 NTRA shares (NASDAQ: NTRA) - Stock Titan
Natera Inc Stock (US6323071042): Analyst calls from RBC and Goldman put diagnostics specialist in fo - AD HOC NEWS
Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says - Moomoo
NTRA & Diakonos partner to use Signatera in refractory melanoma trial - MSN
RBC Capital Maintains Natera(NTRA.US) With Buy Rating, Cuts Target Price to $275 - Moomoo
Natera stock jumps into focus as RBC resumes coverage with Outperform rating and a $275 price target - Business Upturn
RBC Capital initiates Natera stock coverage with outperform rating By Investing.com - Investing.com Australia
RBC Capital initiates Natera stock coverage with outperform rating - Investing.com
Natera (NTRA) Coverage Resumed with Positive Outlook and Price T - GuruFocus
NTRA & CytoDyn partner to advance ctDNA-guided development in mCRC - MSN
Why Natera is my favorite stock idea for the rest of 2026 - MSN
Natera director Marcus Boxer sells $2.39 million in stock - Investing.com UK
Natera Inc. (NTRA) Gains Momentum: Stock Surges 4.38% as Support Holds FirmETH Profile - newsline.com
Natera director Marcus Boxer sells $2.39 million in stock By Investing.com - Investing.com South Africa
Natera (NTRA) director Boxer exercises options and sells 11,000 shares - Stock Titan
Natera : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Thomas J. Lynch Jr. joins Natera (NTRA) insider list with Form 3 filing - Stock Titan
Have Natera Insiders Been Selling Stock? - simplywall.st
NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC - Yahoo Finance
Natera Pushes MRD And Panorama Into Treatment Guiding Roles - Yahoo Finance
Billionaire Stanley Druckenmiller Likes This Cancer Stock - Insider Monkey
How Investors May Respond To Natera (NTRA) Expanding Signatera MRD Reach Amid Insider Share Sale - simplywall.st
Natera, Inc. (NTRA) Stock Analysis: Insights into a High-Growth Diagnostics Leader with a 20% Upside Potential - DirectorsTalk Interviews
This Insider Has Just Sold Shares In Natera - Moomoo
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | CO-FOUNDER |
Jun 15 '26 |
Sale |
211.14 |
3,150 |
665,087 |
249,352 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Jun 15 '26 |
Sale |
214.91 |
50,000 |
10,745,662 |
2,277,843 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Jun 12 '26 |
Sale |
214.03 |
50,000 |
10,701,645 |
2,327,843 |
0.44%
2.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):